Tiotropium in early-stage chronic obstructive pulmonary disease

New England Journal of Medicine

Volumn 377, Issue 10, 2017, Pages 923-935

  Zhou, Y ^a   Zhong, N ^a   Li, Xiaochen ^a   Chen, S ^a   Zheng, J ^a   Zhao, D ^a   Yao, W ^u   Zhi, R ^d   Wei, L ^b   He, B ^g   Zhang, X ^h   Yang, C ⁱ   Li, Ying ^k   Li, F ^c   Du, J ^l   Gui, J ^m   Hu, B ⁿ   Bai, C ^o   Huang, P ^q   Chen, G ^r   Xu, Y ^s   Wang, C ^t   Liang, B ^u   Li, Yinhuan ^d   Hu, G ^b   Tan, H ^g   Ye, X ^h   Ma, X ^k   Chen, Y ^c   Hu, X ^l   Tian, J ^m   Zhu, X ^o   Shi, Z ⁿ   Du, X ^q   Li, M ^r   Liu, S ^f   Yu, R ^p   Zhao, J ^s   Ma, Q ^t   Xie, C ^e   Li, Xiongbin ^v   Chen, T ^j   Lin, Y ^w   Zeng, Lizhen ⁱ   Ye, C ⁱ   Ye, W ^x   Luo, X ^x   Zeng, Lingshan ^x   Yu, S ^x   Guan, W ^a   Ran, P ^a   more..

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b Third Affiliated Hospital   (China)

^c Liwan Hospital of Guangzhou Medical University   (China)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

^e SUN YAT SEN UNIVERSITY   (China)

^f THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^g Chenzhou No 1 People's Hospital   (China)

^h GUIZHOU PROVINCIAL PEOPLE'S HOSPITAL   (China)

ⁱ Wengyuan County People's Hospital   (China)

^j Shaoguan Iron and Steel Group Company Limited Hospital   (China)

^k HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^l GUIZHOU MEDICAL UNIVERSITY   (China)

^m Second People's Hospital of Hunan Province   (China)

ⁿ Huizhou College   (China)

^o ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^p Shanghai Xuhui Central Hospital   (China)

^q The 6th Affiliated Hospital of Shenzhen University Health Science Center   (China)

^r THE FIRST PEOPLE S HOSPITAL OF FOSHAN   (China)

^s HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^t Xinqiao Hospital   (China)

^u GUANGDONG MEDICAL UNIVERSITY   (China)

^v Department of Cardiology   (China)

^w CAPITAL MEDICAL UNIVERSITY   (China)

^x Lianping County People's Hospital   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; IPRATROPIUM BROMIDE; PLACEBO; TIOTROPIUM BROMIDE;

ADULT; ARTICLE; CHINA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OROPHARYNX PAIN; PATIENT COMPLIANCE; PHARYNX DISCOMFORT; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; XEROSTOMIA; AGED; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADMINISTRATION, INHALATION; AGED; BRONCHODILATOR AGENTS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; TIOTROPIUM BROMIDE;

EID: 85029187160     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1700228     Document Type: Article

References (26)

1. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-50.
2. Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007; 176: 753-60.
3. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-128.
4. Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2013; 381: 1987-2015.
5. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3(11): e442.
6. Mapel DW, Dalal AA, Blanchette CM, Petersen H, Ferguson GT. Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims. Int J Chron Obstruct Pulmon Dis 2011; 6: 573-81.
7. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543-54.
8. Vogelmeier C, Hederer B, Glaab T, et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 2011; 364: 1093-103.
9. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 2009; 374: 1171-8.
10. Johansson G, Lindberg A, Romberg K, Nordstrom L, Gerken F, Roquet A. Bronchodilator efficacy of tiotropium in patients with mild to moderate COPD. Prim Care Respir J 2008; 17: 169-75.
11. Tashkin DP, Celli BR, Decramer M, Lystig T, Liu D, Kesten S. Efficacy of tiotropium in COPD patients with FEV1 ≥60% participating in the UPLIFT trial. COPD 2012; 9: 289-96.
12. Li X, Zhou Y, Chen S, Zheng J, Zhong N, Ran P. Early intervention with tiotropium in Chinese patients with GOLD stages I-II chronic obstructive pulmonary disease (Tie-COPD): study protocol for a multicentre, double-blinded, randomised, controlled trial. BMJ Open 2014; 4(2): e003991.
13. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34: 648-54.
14. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003; 1: 13.
15. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). Publication list, 2017 (http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/).
16. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-68.
17. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows: Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal: Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5-40.
18. Zheng J, Zhong N. Normative values of pulmonary function testing in Chinese adults. Chin Med J (Engl) 2002; 115: 50-4.
19. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
20. Troosters T, Celli B, Lystig T, et al. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Eur Respir J 2010; 36: 65-73.
21. Lee HY, Choi SM, Lee J, et al. Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity scorematched analysis of real-world data. Int J Chron Obstruct Pulmon Dis 2015; 10: 2185-92.
22. Zhou Y, Zou Y, Li X, et al. Lung function and incidence of chronic obstructive pulmonary disease after improved cooking fuels and kitchen ventilation: a 9-year prospective cohort study. PLoS Med 2014; 11(3): e1001621.
23. Guan WJ, Zheng XY, Chung KF, Zhong NS. Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action. Lancet 2016; 388: 1939-51.
24. Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis 2012; 7: 95-9.
25. Welte T, Vogelmeier C, Papi A. COPD: early diagnosis and treatment to slow disease progression. Int J Clin Pract 2015; 69: 336-49.
26. 1 decline in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2016; 194: 178-84.